Yang Han, Lin Yongbin, Liang Ying
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
State Key Laboratory of Oncology in South China, Guangzhou, China.
Curr Treat Options Oncol. 2017 Aug 10;18(9):54. doi: 10.1007/s11864-017-0494-9.
Lung carcinosarcoma (PCS) and other histological subtypes of non-small cell lung cancer, such as primary pulmonary lymphoma (PPL), pulmonary carcinoid (PC), and primary pulmonary lymphoepithelioma-like carcinoma (LELC), are rare. For their low incidence, the diagnosis and treatment are still controversial. Some patients only need surgery, while others may need chemotherapy, radiotherapy, or targeted therapy. In this paper, we retrospectively reviewed the literature of some rare histological subtype of NSCLC for the recent 20 years, and try to get some conclusions.
肺肉瘤样癌（PCS）以及非小细胞肺癌的其他组织学亚型，如原发性肺淋巴瘤（PPL）、肺类癌（PC）和原发性肺淋巴上皮瘤样癌（LELC），都较为罕见。由于其发病率低，诊断和治疗仍存在争议。一些患者仅需手术治疗，而另一些患者可能需要化疗、放疗或靶向治疗。在本文中，我们回顾了近20年一些非小细胞肺癌罕见组织学亚型的文献，并试图得出一些结论。
